4 results about "Injectable Solution" patented technology

The current invention relates to a pharmaceutical composition for local or parenteral administration, more specifically an injectable solution comprising of an amino acid composition dissolved in purified hyaluronic acid or a salt or ester thereof, wherein said hyaluronic acid has a molecular weight between 500 kDa and 4000 kDa and wherein said injectable solution comprises a pH between 6.4 and 7.8. In a further aspect, the present invention also relates to use of aforementioned pharmaceutical composition in the treatment of a musculoskeletal disease, such as osteoarthritis, in a subject.

The utility model relates to the technical field of dilution preparation of injection, in particular to a dilution preparation device for glycopyrronium bromide neostigmine injection, which comprises a tank body, a tank cover is arranged at the top of the tank body, a sealing plate is arranged at the joint of the tank body and the tank cover, a first motor is arranged at the top of the tank cover, the output end of the first motor is fixedly connected with a rotating rod, and the rotating rod is fixedly connected with the tank cover. A plurality of lantern rings are arranged on the outer side of the rotating rod, stirring plates are symmetrically arranged on the outer sides of the lantern rings, and feeding nozzles are arranged between the lantern rings. The first motor drives the rotating rod to rotate, the rotating rod rotates to drive the lantern ring and the stirring plate to rotate together, and the stirring plate can be more conveniently detached through the lantern ring, so that the stirring plate is replaced and maintained; the first motor is used for driving the stirring plate to rotate at a low speed, so that injection in the tank body and diluent in the feeding box are stirred and mixed, and meanwhile, other diluent with a small dosage is added through the feeding spray head in the rotating rod.

To provide a method for preventing precipitation caused by the storage of an injection solution for boron neutron capture therapy.SOLUTION: The present invention provides a method for preventing precipitation of an injection solution for boron neutron capture therapy, the injection solution containing: p-boronophenylalanine or a pharmaceutically acceptable salt thereof; a sugar alcohol; and a pH adjusting agent, having a pH of 6.5 to 8.0 and an osmotic pressure ratio of 1.0 to 1.8, and being to be administered by intravenous drip injection.SELECTED DRAWING: None